Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket

Author: Lisa Levin | January 03, 2023 08:55am

Gainers

  • Gorilla Technology Group Inc. (NASDAQ:GRRR) shares rose 162% to $21.30 in pre-market trading after jumping over 35% on Friday. Gorilla Technology recently said it is entering the MENA region with a security convergence offering in a multi-year, multi-million dollar deal.
  • Swvl Holdings Corp. (NASDAQ:SWVL) shares rose 68% to $0.2302 in pre-market trading after the company reported commencement of strategic review process.
  • Novo Integrated Sciences, Inc. (NASDAQ:NVOS) rose 49.1% to $0.2999 in pre-market trading. Novo Integrated Sciences recently announced receipt of notice from Nasdaq.
  • Sorrento Therapeutics, Inc. (NASDAQ:SRNE) rose 33.2% to $1.18 in pre-market trading. Sorrento Therapeutics, last month, received FDA clearance to initiate clinical trials with a next generation mRNA vaccine against omicron SARS-CoV-2 virus.
  • Unicycive Therapeutics, Inc. (NASDAQ:UNCY) shares rose 16.7% to $0.63 in pre-market trading. Unicycive recently reported termination of 'at-the-market' offering of shares of common stock.
  • Cosmos Health Inc. (NASDAQ:COSM) rose 16% to $5.29 in pre-market trading. Cosmos Health recently announced pricing of a $32.5 million registered direct offering and concurrent private placement priced at-the-market.
  • Kala Pharmaceuticals, Inc. (NASDAQ:KALA) rose 14.1% to $43.53 in pre-market trading after gaining over 53% on Friday. Kala Pharmaceuticals recently announced FDA acceptance of an IND application for its KPI-012 for the treatment of persistent corneal epithelial defect.
  • Senmiao Technology Limited (NASDAQ:AIHS) rose 14.1% to $1.03 in pre-market trading after declining around 4% on Friday.
  • Aethlon Medical, Inc. (NASDAQ:AEMD) rose 12.6% to $0.31 in pre-market trading after gaining around 7% on Friday.
  • Rubius Therapeutics, Inc. (NASDAQ:RUBY) rose 10.4% to $0.19 in pre-market trading after declining 9% on Friday.
  • Cellectis S.A. (NASDAQ:CLLS) rose 10.3% to $2.32 in pre-market trading after gaining around 8% on Friday.
  • Mullen Automotive, Inc. (NASDAQ:MULN) shares rose 9.4% to $0.3130 in pre-market trading after gaining over 8% on Friday.
  • Meiwu Technology Company Limited (NASDAQ:WNW) rose 8.7% to $0.2076 in pre-market trading after declining 5% on Friday.
  • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) rose 8.7% to $0.78 in pre-market trading after gaining more than 6% on Friday.
  • Li Auto Inc. (NASDAQ:LI) rose 7.3% to $21.88 in pre-market trading. Li Auto said it delivered 21,233 vehicles in December, marking a record monthly performance. In the fourth quarter, the company sold 46,319 cars.
  • Getaround, Inc. (NYSE:GETR) rose 7.3% to $0.70 in pre-market trading after gaining more than 30% on Friday. Piper Sandler recently initiated coverage on Getaround with an Overweight rating and announced a price target of $1.5.
  • XPeng Inc. (NYSE:XPEV) rose 6.7% to $10.61 in pre-market trading. XPeng sold 11,292 units for December and 22,204 units for the fourth quarter.
  • Pagaya Technologies Ltd. (NASDAQ:PGY) rose 5.7% to $1.31 in pre-market trading after dropping around 7% on Friday.
  • NIO Inc. (NYSE:NIO) rose 4.2% to $10.16 in pre-market trading as the company reported that it delivered 15,815 vehicles in December, marking a new record-high monthly delivery, and also representing a 50.8% year-over-year growth. It delivered 40,052 vehicles during the fourth quarter, representing a surge of 60.0% year-over-year.


Losers

  • Bit Brother Limited (NASDAQ:BTB) shares fell 17.2% to $8.80 in pre-market trading after gaining over 9% on Friday. Bit Brother, last month, announced a 1-for-15 reverse share split.
  • Argo Blockchain plc (NASDAQ:ARBK) fell 14.9% to $0.9187 in pre-market trading after jumping around 19% on Friday. Argo Blockchain recently entered into definitive agreements with Galaxy Digital Holdings, under which an Argo subsidiary will sell its Helios facility in Dickens County, Texas for $65 million.
  • Silo Pharma, Inc. (NASDAQ:SILO) fell 14.8% to $2.86 in pre-market trading. Silo Pharma, on Friday, reported interim data from its dose optimization study of SPU-21 joint homing peptides for subcutaneous administration of anti-arthritic agents.
  • Dermata Therapeutics, Inc. (NASDAQ:DRMA) shares fell 12% to $0.36 in pre-market trading. Dermata Therapeutics shares jumped over 100% on Friday after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.
  • TransCode Therapeutics, Inc. (NASDAQ:RNAZ) fell 10.8% to $0.60 in pre-market trading after gaining 18% on Friday. TransCode Therapeutics recently announced it received written authorization from the FDA that it may proceed with its First-in-Human Phase 0 clinical trial.
  • ToughBuilt Industries, Inc. (NASDAQ:TBLT) fell 9.4% to $2.12 in pre-market trading after jumping 18% on Friday.
  • GreenLight Biosciences Holdings (NASDAQ:GRNA) fell 9.3% to $1.07in pre-market trading after gaining over 5% on Friday.
  • Sphere 3D Corp. (NASDAQ:ANY) fell 9.2% to $0.2501 in pre-market trading.
  • Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) fell 8.8% to $0.41 in pre-market trading after gaining 26% on Friday.
  • Reed's, Inc. (NASDAQ:REED) fell 8.5% to $0.0638 in pre-market trading.
  • Korea Electric Power Corporation (NYSE:KEP) shares fell 8% to $7.95 in pre-market trading.
  • TG Therapeutics, Inc. (NASDAQ:TGTX) shares fell 5.5% to $11.18 in pre-market trading after gaining around 14% on Friday. B. Riley Securities maintained a Buy rating on the stock and raised its price target from $17 to $23.
  • Tesla, Inc. (NASDAQ:TSLA) fell 4.2% to $118.05 in pre-market trading after the company reported fourth-quarter deliveries that came in below market estimates. The company delivered more than 405,278 cars in the fourth quarter, and produced over 439,000. This represented a 31.33% year-over-year rise and a 17.87% sequential growth. The consensus estimate for Q4 deliveries compiled by Tesla’s investor relations was 417,957 units.

Check This Out: Investor Fear Eases Slightly On Last Trading Day Of 2022

Posted In: AEMD AGLE AIHS ANY ARBK BTB CLLS COSM DRMA GETR GRNA GRRR KALA KEP LI MULN NIO NRBO NVOS PGY

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist